HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.106.038612v1 48/9/1553    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, K. I. Articles by Lee, M. C. Search for Related Content PubMed PubMed Citation Articles by Kim, K. I. Articles by Lee, M. C.

Doxorubicin Enhances the Expression of Transgene Under Control of the CMV Promoter in Anaplastic Thyroid Carcinoma Cells

¹ Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea; ² Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Korea; ³ Tumor Immunity Medical Research Center, Seoul National University College of Medicine, Seoul, Korea; and ⁴ Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

Correspondence: For correspondence or reprints contact: June-Key Chung, MD, PhD, Department of Nuclear Medicine, Seoul National University Hospital, 28, Yongon-dong, Jongno-gu, Seoul 110-744, Korea. E-mail: jkchung{at}plaza.snu.ac.kr

We investigated the effect of doxorubicin on transgene expression and evaluated the mechanism of enhanced transgene expression by doxorubicin in transfected human anaplastic thyroid cancer cells (ARO cells). Methods: ARO cells were transfected with plasmid vectors or adenoviral vectors expressing human sodium/iodide symporter (hNIS) or luciferase (Luc) under the control of cytomegalovirus (CMV) promoter. After treating transfected and control ARO cells with doxorubicin, iodide uptake assay and luciferase assay were performed. Reversed-phase polymerase chain reaction analysis for hNIS and Western blot analysis for IB protein were executed. Electrophoretic mobility-shift assay (EMSA) was performed to evaluate nuclear factor-B (NF-B) binding activity induced by doxorubicin. Scintigraphic and bioluminescent images were acquired and quantitated before and after doxorubicin in a tumor-bearing mouse model. Results: Radioiodide uptake in ARO cells transfected with the NIS gene under the CMV promoter was remarkably enhanced by doxorubicin, and this corresponded to a significant increase in NIS messenger RNA. In addition, luciferase gene upregulation by doxorubicin was also observed in luciferase gene transfected ARO cells. These results were verified by in vivo imaging in a tumor-bearing mouse model. Moreover, transgene expressional enhancement by doxorubicin was observed after transfecting ARO cells with adenoviral vector or plasmid vector, when transgenes were under the control of a CMV promoter. In addition, NF-B, activated by doxorubicin, induced transgene transcription under the control of the CMV promoter, which possesses an NF-B binding site. Conclusion: These findings indicate that doxorubicin enhances transgene expression under the control of the CMV promoter and that doxorubicin might be used as an adjuvant to radioiodine therapy by NIS gene transfer in anaplastic thyroid carcinoma.

Key Words: anaplastic thyroid cancer • doxorubicin • transgene • imaging reporter gene • gene therapy

COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2007 48: 11A-12A. [Full Text]  

This article has been cited by other articles:

				S.-Y. Park, W. Kwak, N. Tapha, M.-Y. Jung, J.-O. Nam, I.-S. So, S.-Y. Kim, J. Yoo, J. Lee, and I.-S. Kim Combination Therapy and Noninvasive Imaging with a Dual Therapeutic Vector Expressing MDR1 Short Hairpin RNA and a Sodium Iodide Symporter J. Nucl. Med., September 1, 2008; 49(9): 1480 - 1488. [Abstract] [Full Text] [PDF]

				J. H. Kang and J.-K. Chung Molecular-Genetic Imaging Based on Reporter Gene Expression J. Nucl. Med., June 1, 2008; 49(Suppl_2): 164S - 179S. [Abstract] [Full Text] [PDF]